Northern Trust Corp Cytokinetics Inc Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Cytokinetics Inc stock. As of the latest transaction made, Northern Trust Corp holds 1,329,654 shares of CYTK stock, worth $65.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,329,654
Previous 1,282,893 3.64%
Holding current value
$65.3 Million
Previous $69.5 Million 1.0%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$51.22 - $60.16 $2.4 Million - $2.81 Million
46,761 Added 3.64%
1,329,654 $70.2 Million
Q2 2024

Aug 14, 2024
BUY
$47.86 - $75.05 $8.21 Million - $12.9 Million
171,453 Added 15.43%
1,282,893 $69.5 Million
Q1 2024

May 14, 2024
BUY
$63.75 - $108.06 $3.54 Million - $5.99 Million
55,463 Added 5.25%
1,111,440 $77.9 Million
Q4 2023

Feb 13, 2024
SELL
$26.88 - $83.49 $464,163 - $1.44 Million
-17,268 Reduced 1.61%
1,055,977 $88.2 Million
Q3 2023

Nov 13, 2023
SELL
$29.46 - $36.61 $768,552 - $955,081
-26,088 Reduced 2.37%
1,073,245 $31.6 Million
Q2 2023

Aug 11, 2023
BUY
$32.62 - $40.75 $2.88 Million - $3.6 Million
88,408 Added 8.75%
1,099,333 $35.9 Million
Q1 2023

May 15, 2023
BUY
$33.36 - $45.71 $4,270 - $5,850
128 Added 0.01%
1,010,925 $35.6 Million
Q4 2022

Feb 13, 2023
BUY
$35.77 - $51.11 $659,813 - $942,775
18,446 Added 1.86%
1,010,797 $46.3 Million
Q3 2022

Nov 14, 2022
BUY
$38.54 - $54.52 $797,199 - $1.13 Million
20,685 Added 2.13%
992,351 $48.1 Million
Q2 2022

Aug 12, 2022
BUY
$33.93 - $48.92 $233,404 - $336,520
6,879 Added 0.71%
971,666 $38.2 Million
Q1 2022

May 13, 2022
SELL
$29.74 - $46.0 $1.33 Million - $2.05 Million
-44,558 Reduced 4.41%
964,787 $35.5 Million
Q4 2021

Feb 08, 2022
SELL
$34.35 - $46.38 $20,438 - $27,596
-595 Reduced 0.06%
1,009,345 $46 Million
Q3 2021

Nov 15, 2021
BUY
$18.54 - $35.74 $1.9 Million - $3.66 Million
102,360 Added 11.28%
1,009,940 $36.1 Million
Q2 2021

Aug 13, 2021
BUY
$19.79 - $26.99 $1.93 Million - $2.63 Million
97,399 Added 12.02%
907,580 $18 Million
Q1 2021

May 12, 2021
SELL
$18.57 - $25.68 $506,515 - $700,447
-27,276 Reduced 3.26%
810,181 $18.8 Million
Q4 2020

Feb 11, 2021
SELL
$15.26 - $28.61 $617,709 - $1.16 Million
-40,479 Reduced 4.61%
837,457 $17.4 Million
Q3 2020

Nov 16, 2020
BUY
$20.58 - $28.96 $1.7 Million - $2.39 Million
82,571 Added 10.38%
877,936 $19 Million
Q2 2020

Aug 14, 2020
BUY
$11.15 - $24.64 $245,935 - $543,484
22,057 Added 2.85%
795,365 $18.7 Million
Q1 2020

May 14, 2020
BUY
$8.75 - $16.3 $69,125 - $128,770
7,900 Added 1.03%
773,308 $9.12 Million
Q4 2019

Feb 14, 2020
SELL
$7.95 - $11.84 $200,419 - $298,486
-25,210 Reduced 3.19%
765,408 $8.12 Million
Q3 2019

Nov 13, 2019
BUY
$10.82 - $14.25 $1.23 Million - $1.62 Million
113,633 Added 16.79%
790,618 $9 Million
Q2 2019

Aug 13, 2019
BUY
$7.95 - $11.25 $1.06 Million - $1.5 Million
133,189 Added 24.49%
676,985 $7.62 Million
Q1 2019

May 13, 2019
BUY
$5.95 - $10.19 $68,240 - $116,869
11,469 Added 2.15%
543,796 $4.4 Million
Q4 2018

Feb 12, 2019
SELL
$5.91 - $9.29 $76,753 - $120,649
-12,987 Reduced 2.38%
532,327 $3.36 Million
Q3 2018

Nov 14, 2018
BUY
$6.4 - $9.85 $299,315 - $460,664
46,768 Added 9.38%
545,314 $5.37 Million
Q2 2018

Sep 18, 2018
SELL
$6.9 - $9.9 $23,487 - $33,699
-3,404 Reduced 0.68%
498,546 $4.14 Million
Q2 2018

Aug 14, 2018
BUY
$6.9 - $9.9 $516,271 - $740,737
74,822 Added 17.52%
501,950 $4.17 Million
Q1 2018

May 09, 2018
BUY
$7.2 - $10.05 $4,860 - $6,783
675 Added 0.16%
427,128 $3.08 Million
Q4 2017

Feb 14, 2018
SELL
$7.25 - $15.65 $329,186 - $710,588
-45,405 Reduced 9.62%
426,453 $3.48 Million
Q3 2017

Nov 13, 2017
BUY
$12.0 - $15.0 $5.66 Million - $7.08 Million
471,858
471,858 $6.84 Million

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.62B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email